NDC 0185-0749

Carisoprodol, Aspirin and Codeine Phosphate

Carisoprodol, Aspirin And Codeine Phosphate

Carisoprodol, Aspirin and Codeine Phosphate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Eon Labs, Inc.. The primary component is Carisoprodol; Aspirin; Codeine Phosphate.

• Product ID: 0185-0749_e1eaeba6-7e4b-4851-9554-8564fc7c4c72
• NDC: 0185-0749
• Product Type: Human Prescription Drug
• Proprietary Name: Carisoprodol, Aspirin and Codeine Phosphate
• Generic Name: Carisoprodol, Aspirin And Codeine Phosphate
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 1996-04-16
• Marketing End Date: 2019-09-30
• Marketing Category: ANDA / ANDA
• Application Number: ANDA040118
• Labeler Name: Eon Labs, Inc.
• Substance Name: CARISOPRODOL; ASPIRIN; CODEINE PHOSPHATE
• Active Ingredient Strength: 200 mg/1; mg/1; mg/1
• Pharm Classes: Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Full Opioid Agonists [MoA],Opioid Agonist [EPC]
• DEA Schedule: CIII
• NDC Exclude Flag: N

Packaging

NDC 0185-0749-05

500 TABLET in 1 BOTTLE (0185-0749-05)

• Marketing Start Date: 1996-04-16
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0185-0749-05 [00185074905]

Carisoprodol, Aspirin and Codeine Phosphate TABLET

• Marketing Category: ANDA
• Application Number: ANDA040118
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1996-04-16
• Marketing End Date: 2019-09-30

NDC 0185-0749-01 [00185074901]

Carisoprodol, Aspirin and Codeine Phosphate TABLET

• Marketing Category: ANDA
• Application Number: ANDA040118
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1996-04-16
• Marketing End Date: 2019-09-30

NDC 0185-0749-10 [00185074910]

Carisoprodol, Aspirin and Codeine Phosphate TABLET

• Marketing Category: ANDA
• Application Number: ANDA040118
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1996-04-16
• Marketing End Date: 2019-09-30

Drug Details

Active Ingredients

Ingredient	Strength
CARISOPRODOL	200 mg/1

OpenFDA Data

• SPL SET ID: dcae7a8a-9d9e-4f7f-954c-39e371f30f75
• Manufacturer:
  • Eon Labs, Inc.
• UNII:
  • GSL05Y1MN6
  • R16CO5Y76E
  • 21925K482H
• RxNorm Concept Unique ID - RxCUI:
  • 994226
• Pharm Class PE:
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
• PHarm Class EPC:
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
• NUI Code:
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

Pharmacological Class

• Centrally-mediated Muscle Relaxation [PE]
• Muscle Relaxant [EPC]
• Cyclooxygenase Inhibitors [MoA]
• Decreased Prostaglandin Production [PE]
• Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
• Nonsteroidal Anti-inflammatory Drug [EPC]
• Platelet Aggregation Inhibitor [EPC]
• Decreased Platelet Aggregation [PE]
• Full Opioid Agonists [MoA]
• Opioid Agonist [EPC]

NDC Crossover Matching brand name "Carisoprodol, Aspirin and Codeine Phosphate" or generic name "Carisoprodol, Aspirin And Codeine Phosphate"

NDC	Brand Name	Generic Name
0185-0749	Carisoprodol, Aspirin and Codeine Phosphate	Carisoprodol, Aspirin and Codeine Phosphate
50742-256	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	carisoprodol, aspirin and codeine phosphate
64980-176	Carisoprodol, Aspirin and Codeine Phosphate	Carisoprodol, Aspirin and Codeine Phosphate